November 6, 2014 / 8:53 PM / 4 years ago

BUZZ-U.S. Stocks on the Move-Planar, Solazyme,

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter, U.S. stocks edged up in a volatile session on Thursday, with the Dow and S&P 500 hitting fresh records on an indication that the European Central Bank would take more policy action if needed to boost a struggling euro zone economy. The Dow Jones industrial average was up 0.40 percent at 17,554.82, the S&P 500 was up 0.37 percent at 2,031.05 and the Nasdaq Composite was up 6.26 points, or 0.14 percent, to 4,626.98.

** GENWORTH FINANCIAL INC, $8.71, -38.10 pct

The life and mortgage insurer said it would suspend dividends in its life business until the end of next year, and that it was open to all strategic options.

** AETERNA ZENTARIS INC, $0.64, -50.39 pct

The drugmaker said the U.S. Food and Drug Administration rejected macimorelin, an experimental test designed to determine if adults’ pituitary glands are secreting enough growth hormone.

** PLANAR SYSTEMS INC, $6.35, +71.62 pct

Needham raised its rating on the digital signage company’s stock to “buy” from “neutral”, while B. Riley raised its price target to $6 after it forecast first-quarter profit and revenue above analysts’ estimates.

** SOLAZYME INC, $3.1901, -57.41 pct

The oil producer’s third-quarter loss widened year-over-year and revenue missed market estimates. Baird cut its rating on the stock to “neutral” from “outperform” and cut its price target to $9 from $16.

Cowen and Company cut its rating to “market perform” from “outperform” and target to $7 from $12, citing ‘sub-par results’.

** ANDERSONS INC, $52.0201, -17.96 pct

The grain handler’s third-quarter profit lagged average analyst expectation as revenue dropped 19 percent, hurt mainly by lower commodity prices.

The company also said poor railroad service would “impact” its performance this quarter.


The drugmaker reported better-than-expected third-quarter revenue and said it had completed hiring a field sales force to launch its drug ferric citrate in the United States next month.

Ferric citrate, which won approval in September, helps lower phosphate levels in patients with chronic kidney disease.

** STONEGATE MORTGAGE CORP, $12.01, -14.46 pct

The mortgage servicing company reported a third-quarter profit that was lower than the average analyst expectation. Expenses more than double to $61.4 million, hurt by higher interest payments. (


The nuclear and waste management service provider reported better-than-expected third-quarter profit and revenue, driven by higher volume in its treatment unit and cost reduction initiatives.


The drugmaker agreed to buy British drugmaker AstraZeneca Plc’s rare disease drug Myalept for $325 million upfront and estimated peak net sales of $200-$250 million.

Myalept is the only FDA-approved drug for use in generalized lipodystrophy - a skin condition characterized by an extreme scarcity of fat in subcutaneous tissue.

** SILVER SPRING NETWORKS INC, $7.58, -14.35 pct

At least three brokerages cut their price targets on the electricity grid management services provider’s stock to $9.50-$13. The company said on Wednesday that CEO Scott Lang will step down.

** CHEMOCENTRYX INC, $4.8, -13.20 pct

The drug developer did not recognize any revenue for the third quarter and posted a loss 13 percent wider than last year. Analyst Eric Schmidt at Cowen and Company downgraded the stock to “market perform” from “outperform”. Schmidt said the company had limited revenue with no approved products and would need to raise additional capital to fund its operations.

** TREE.COM INC, $43.66, +20.74 pct

The loan and real estate information provider raised its full-year revenue guidance to $164 million-166 million from $160.1 million-$164.3 million. The company said its third-quarter revenue increased 11 percent to $41.3 million as non-mortgage products more than doubled.

** CORNERSTONE ONDEMAND INC, $27.62, -15.66 pct

The human resource management software maker forecast fourth-quarter revenue below average analyst estimate on Wednesday and cut its full-year revenue forecast to $260 million-$263 million from $267.5 million-$270.5 million .

At least five brokerages cut their price targets on the company’s stock to a range of $34-$45.

** TEARLAB CORP, $2.25, -15.73 pct

The diagnostic product maker reported weaker-than-expected third-quarter sales on Wednesday.

Roth Capital cut its price target on the stock by $1 to $4 and Canaccord Genuity halved its price target to $4.


The asset manager’s third-quarter earnings per share rose to 10 cents from 1 cent last year, when the company was part of NorthStar Realty Finance Corp.


The communication services company raised its full-year revenue forecast to $315 million from $310 million as demand for broadband services increased.

** PHOTOMEDEX INC, $2.98, -9.70 pct

The dermatology product maker reported a third-quarter loss, missing average analyst expectation for the fifth straight quarter.

The company said on Tuesday that it had defaulted on a credit facility and hired Canaccord Genuity to explore strategic alternatives.

** TRIANGLE CAPITAL CORP, $22.54, -11.40 pct

The business development company’s third-quarter net investment income per share that fell to 51 cents from 61 cents a year earlier.

The company’s loan interest and dividend income fell.

** COHERUS BIOSCIENCES, $12.5, -7.41 pct

The late-stage clinical biologics platform company filed a revised prospectus, indicating a 2-month delay in completing rheumatoid arthritis and psoriasis trials, and assured particulate-free tests.

** BIOSCRIP INC, $5.59, -10.42 pct

The home healthcare provider reported a loss of 42 cents per share - its fourth straight quarterly loss. Analysts on average had expected a profit of 2 cents per share.

** ZILLOW INC, $99.545, -4.07 pct

The real estate website operator forecast fourth-quarter revenue of $89 million-$90 million on Wednesday. Analysts on average were expecting $90.82 million.

“Q4 forecast reflected decelerating display revenue and a likely sequential deceleration in average revenue per user. Third-quarter net loss widened largely due to costs related to Trulia Inc acquisition,” Stephens Inc analyst John Campbell wrote.

** AMC NETWORKS INC, $61.055, +1.86 pct

The cable TV network reported better-than-expected third-quarter revenue and profit, helped by its purchase of content provider Chellomedia which drove growth in its international business.

** RADNET INC, $9.77, +2.20 pct

The diagnostic imaging center operator raised its 2014 revenue forecast to $730 million-$745 million from $700 million-$730 million, citing growth in imaging procedure volumes, partnerships with hospitals and the licensing out of its imaging information technology.

** KATE SPADE & CO, $30.965, +17.92 pct

The company reported a 30 percent rise in third-quarter sales as demand for its handbags and accessories increased in North America, its biggest market.

** QUALCOMM INC, $70.34, -8.89 pct

The company warned on Wednesday that an antitrust investigation and problems collecting royalties could harm its business in China next year and it also disclosed new regulatory investigations in the United States and Europe.

As many as nine brokerages cut their price targets on the stock on Thursday.

** HOSPIRA INC, $56.68, +6.74 pct

The drugmaker reported a 14.1 percent rise in quarterly revenue as it charged higher prices and sold more of its injectable drugs.

** KINROSS GOLD CORP , $2.265, +13.25 pct

** IAMGOLD CORP , $1.725, +13.49 pct

** HECLA MINING CO, $2.175, +6.62 pct

** SEABRIDGE GOLD INC , $6.34, +6.20 pct

** ELDORADO GOLD CORP , $5.29, +5.59 pct

** AURICO GOLD INC , $3.03, +2.71 pct

** BARRICK GOLD CORP , $11.4, +3.92 pct

** ENDEAVOUR SILVER CORP , $2.86, +7.12 pct

Gold and silver miners’ U.S.-listed shares rose after gold edged higher from four-year lows as a retreating dollar eased some pressure.

Spot gold was up 0.48 percent at $1,146.60 per ounce and spot silver was up 0.33 percent at $15.38 per ounce by 11 a.m. ET.

** GENERAC HOLDINGS INC, $42.1, -3.26 pct

The generator maker said it expects a mid single-digit percentage fall in 2014 revenue, hurt by fewer-than-usual power outages in United States

** AMERICAN CAPITAL LTD, $15.63, +6.62 pct

The private equity firm and asset manager said it plans to split into three companies by spinning off most of its investment assets into two publicly-traded business development companies and continue as an asset manager.

** HORIZON PHARMA PLC, $13.12, +6.15 pct

The drugmaker posted better-than-expected third quarter adjusted profit and revenue. Revenue jumped three-fold to $75.1 million. The company also raises its FY14 and FY15 revenue forecasts, based on expectations for its genetic disorder drug Actimmune and its recently acquired U.S. rights to pain drug “Pennsaid 2%”.

** WEBMD HEALTH CORP, $38.21, -7.41 pct

The health information provider reported third-quarter earnings of 23 cents per share on Wednesday, a penny shy of the average analyst estimate, hurt by a higher operational costs.

Cowen & Co cut its target price on the stock to $42 from $47 and Leerink to $58 from $60.

** WEB.COM GROUP INC, $14.85, -26.67 pct

At least three brokerages cut their price targets on the Internet domain name registration company’s stock by as much as $15 to as low as $20, after it forecast current-quarter revenue below the analysts’ average estimate.

** NU SKIN ENTERPRISES INC, $40.4, -7.68 pct

Canaccord Genuity cuts its target price on the seller of anti-ageing and nutritional products’ shares to $45 from $53 after the cut its fourth-quarter profit and sales forecasts on Wednesday.

** NOODLES & CO, $25.97, +13.85 pct

The fast-casual restaurant chain operator, on Wednesday, reported better-than-expected third quarter sales. Both Wedbush Securities and RBC Capital Markets raised their price targets on the stock to $25 from $21.

** VALE SA, $9.165, -4.13 pct

Spot iron ore prices fall to their lowest since 2009 and are likely to drop further due to a well-supplied market that has reduced the need for Chinese steel mills to restock. Prices of iron ore, a major source of revenue for Vale, have tumbled more than 43 percent this year.


The mortgage servicer reported a third quarter loss due to a fall in fees from mortgage servicing and sale of loans, and higher expenses and taxes.

** NEVRO CORP, $25.26, +40.33 pct

Shares of the medical device company opened at $23.40 in its debut and rose as much as 43 percent to high of $25.75, valuing the company at $586.9 million.

** SENOMYX INC, $6.5128, -8.53 pct

The food ingredient maker cut its full-year sales forecast; and said it expected a bigger loss

** PERION NETWORK LTD, $6.12, +19.07 pct

The Israeli internet company reported a higher quarterly profit and raised its 2014 earnings forecast, helped by layoffs and other cost-cutting steps.

** SAFE BULKERS INC, $4.77, -3.05 pct

The dry bulk shipper reported a surprise quarterly loss, hurt by lower charter rates for its vessels.

** COTT CORP, $6.37, +5.12 pct

The Canadian soft drink maker will acquire U.S. direct-to-consumer water and coffee provider DSS Group Inc, parent of DS Services of America Inc, for $1.25 billion.

** SIERRA WIRELESS INC, $33.44, +26.00 pct

The Canadian company said it expects a fourth quarter adjusted profit of 25-28 cents per share, higher than analysts’ average estimate of 18 cents, according to Thomson Reuters I/B/E/S.

** FOX FACTORY HOLDING CORP, $14.85, -8.78 pct

The maker of suspension products for mountain bikes and all-terrain vehicles reported a third quarter profit that missed the average analyst expectation as operating expenses rose 39 percent.

** RANDGOLD RESOURCES LTD, $65.03, +9.92 pct

The chief executive of the gold miner said production will be towards the top end of the company’s full-year forecast as its big new project in the Democratic Republic of Congo picks up speed.

** THORATEC CORP, $26.1, -3.48 pct

The heart device maker’s third quarter revenue fell 16 percent to $$105.8 million, missing analysts’ estimates.

** AES CORP, $13.05, -6.45 pct

The power company lowered its full-year adjusted earnings forecast to $1.25-1.31 from $1.30-$1.38 due to lower water inflows at plants and a higher-than-expected tax rate.

** TABLEAU SOFTWARE INC, $84.24, +10.12 pct

At least seven brokerages raised their price targets on the data analytics software maker’s shares by as much as $22 to as much as $130 after it reported better-than-expected third quarter profit and revenue on Wednesday.


The mortgage servicer’s third quarter revenue plunged 20 percent and missed analysts’ average estimate, as fees from mortgage servicing and sale of loans fell.

** TESLA MOTORS INC, $239.74, +3.80 pct

The electric-car maker beat analysts’ expectations for third-quarter results. The automaker said its quarterly loss nearly doubled from a year ago to $75 million, as manufacturing, sales and development expenses increased to meet rising demand for its Model S sedan.

** MOLYCORP INC, $1.25, -11.35 pct

The company, which produces 13 different rare metals used in industries such as consumer electronics and defense, reported a much bigger quarterly loss, hurt by lower prices of rare-earth metals and a steep jump in production costs.

** WHOLE FOODS MARKET INC, $44.75, +11.90 pct

The upscale grocer reported a better-than-expected quarterly profit as the company increased its market share and launched new products.

** PETROLEO BRASILEIRO SA, $10.745, -3.72 pct

Brazil’s state-run oil company has no date or size for a widely expected increase in the domestic price of gasoline and diesel, the company said on Wednesday.

** PRUDENTIAL FINANCIAL INC, $85.05, -4.34 pct

The second-largest U.S. life insurer reported a quarterly profit that fell short of market estimates by a wide margin, mainly due to losses tied to its derivatives program. (Compiled by Avik Das in Bangalore; Editing by Simon Jennings)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below